https://medicaldialogues.in/news/industry/pharma/merck-ervebo-gets-usfda-nod-for-prevention-of-disease-caused-by-zaire-ebolavirus-in-children-aged-12-months-and-older-115371
Merck Ervebo gets USFDA nod for prevention of disease caused by Zaire ebolavirus in children aged 12 months and older